| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/BI00034A021 |
| P953 | full work available at URL | https://pubs.acs.org/doi/pdf/10.1021/bi00034a021 |
| P698 | PubMed publication ID | 7662668 |
| P2093 | author name string | J. W. Baynes | |
| S. R. Thorpe | |||
| S. Reddy | |||
| J. Bichler | |||
| K. J. Wells-Knecht | |||
| P433 | issue | 34 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | N(6)-Carboxymethyl-DL-lysine | Q4214591 |
| Maillard reaction | Q647574 | ||
| P304 | page(s) | 10872-10878 | |
| P577 | publication date | 1995-08-01 | |
| 1995-08-29 | |||
| P1433 | published in | Biochemistry | Q764876 |
| P1476 | title | N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins | |
| N.epsilon.-(Carboxymethyl)lysine Is a Dominant Advanced Glycation End Product (AGE) Antigen in Tissue Proteins | |||
| P478 | volume | 34 |
| Q37788385 | 1-Amino-1-deoxy-D-fructose ("fructosamine") and its derivatives. |
| Q33735123 | 3-Deoxyglucosone: metabolism, analysis, biological activity, and clinical implication |
| Q35310202 | 4-Hydroperoxy-2-nonenal is not just an intermediate but a reactive molecule that covalently modifies proteins to generate unique intramolecular oxidation products |
| Q36970464 | A carnosine intervention study in overweight human volunteers: bioavailability and reactive carbonyl species sequestering effect |
| Q41817733 | A quantitative model of the generation of N(epsilon)-(carboxymethyl)lysine in the Maillard reaction between collagen and glucose |
| Q51747235 | AGE-RAGE Stress, Stressors, and Antistressors in Health and Disease. |
| Q50058403 | Accumulation of carboxymethyl-lysine (CML) in human cortical bone. |
| Q43664495 | Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine |
| Q92854689 | Advanced Glycation End-Products Can Activate or Block Bitter Taste Receptors |
| Q28551744 | Advanced Glycation Endproducts and Bone Material Properties in Type 1 Diabetic Mice |
| Q64095043 | Advanced glycation end products (AGE) and receptor for AGE (RAGE) in patients with active tuberculosis, and their relationship between food intake and nutritional status |
| Q36671087 | Advanced glycation end products acutely impair ca(2+) signaling in bovine aortic endothelial cells |
| Q37088388 | Advanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling women |
| Q34981419 | Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women |
| Q24530074 | Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells |
| Q41521328 | Advanced glycation end products promote ChREBP expression and cell proliferation in liver cancer cells by increasing reactive oxygen species |
| Q35878806 | Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways. |
| Q36643573 | Advanced glycation end products: Key players in skin aging? |
| Q73043248 | Advanced glycation end products: detection and reversal |
| Q47970485 | Advanced glycation endproducts in human diabetic and non-diabetic cataractous lenses |
| Q38741489 | Advanced glycation of high-density lipoprotein and the functionality of aldosterone release in type 2 diabetes |
| Q34217710 | Advanced glycation/glycoxidation endproduct carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adults |
| Q44528051 | Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway. |
| Q38083020 | Amadori glycated proteins: role in production of autoantibodies in diabetes mellitus and effect of inhibitors on non-enzymatic glycation. |
| Q71717739 | Amyloid beta 2-microglobulin is modified with N epsilon-(carboxymethyl)lysine in dialysis-related amyloidosis |
| Q71974488 | Amyloid beta 2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis |
| Q83388857 | An explorative analysis of secretory receptor for advanced glycation endproducts in primary focal segmental glomerulosclerosis |
| Q48188316 | An immunochemical study on tau glycation in paired helical filaments |
| Q47947254 | An overview of in vitro and in vivo glycation of albumin: a potential disease marker in diabetes mellitus |
| Q33673698 | Angiotensin II receptor blocker telmisartan attenuates aortic stiffening and remodelling in STZ-diabetic rats |
| Q46918041 | Anthraquinones from the seeds of Cassia tora with inhibitory activity on protein glycation and aldose reductase |
| Q44343992 | Antibodies to advanced glycation end products in children with diabetes mellitus |
| Q36101386 | Antiglycation and Antioxidant Properties of Momordica charantia |
| Q58693389 | Antioxidant Activity and In Vitro Antiglycation of the Fruit of |
| Q37015677 | Association between serum carboxymethyl-lysine, a dominant advanced glycation end product, and anemia in adults: the Baltimore longitudinal study of aging |
| Q34107554 | Atherosclerosis and diabetes: the RAGE connection |
| Q40558928 | Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products |
| Q37641274 | Biochemical biomarkers of oxidative collagen damage. |
| Q28487790 | Biodistribution and elimination study of fluorine-18 labeled Nε-carboxymethyl-lysine following intragastric and intravenous administration |
| Q37404625 | Biologic variability in plasma glucose, hemoglobin A1c, and advanced glycation end products associated with diabetes complications |
| Q35576070 | Carbonyl Stress and Diabetic Complications |
| Q37088397 | Carboxymethyl-lysine, an advanced glycation end product, and decline of renal function in older community-dwelling adults |
| Q51574361 | Carboxymethylethanolamine, a Biomarker of Phospholipid Modification during the Maillard Reaction in Vivo |
| Q38831558 | Cellular mechanisms and consequences of glycation in atherosclerosis and obesity |
| Q30740433 | Characterization of antibody affinities using an AGE-modified dipeptide spot library |
| Q36320445 | Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor |
| Q42157623 | Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence |
| Q35911173 | Circulating levels of carboxy‐methyl‐lysine (CML) are associated with hip fracture risk: the Cardiovascular Health Study |
| Q36040868 | Circulating selenium and carboxymethyl-lysine, an advanced glycation endproduct, are independent predictors of anemia in older community-dwelling adults |
| Q34214276 | Comparative biology of aging in birds: an update |
| Q43914871 | Conformational study of N(epsilon)-(carboxymethyl)lysine adducts of recombinant gammaC-crystallin |
| Q74480911 | Conversion of Amadori product of Maillard reaction to Nepsilon-(carboxymethyl)lysine in alkaline condition |
| Q41886296 | Detection of noncarboxymethyllysine and carboxymethyllysine advanced glycation end products (AGE) in serum of diabetic patients |
| Q36373016 | Determinants of bone strength and quality in diabetes mellitus in humans |
| Q35645788 | Development of Diagnostic Fragment Ion Library for Glycated Peptides of Human Serum Albumin: Targeted Quantification in Prediabetic, Diabetic, and Microalbuminuria Plasma by Parallel Reaction Monitoring, SWATH, and MSE |
| Q33593614 | Development of capture assays for different modifications of human low-density lipoprotein |
| Q40445812 | Development of monoclonal antibodies specific for glycated prion protein. |
| Q37486465 | Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions |
| Q44474816 | Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice |
| Q37733102 | Dietary hyperglycemia, glycemic index and metabolic retinal diseases |
| Q30484885 | Dissociation of functional status from accrual of CML and RAGE in the aged mouse brain. |
| Q35855482 | Effect of Advanced Glycation End Products on Human Thyroglobulin's Antigenicity as Identified by the Use of Sera from Patients with Hashimoto's Thyroiditis and Gestational Diabetes Mellitus |
| Q78109086 | Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats |
| Q43075154 | Effect of glycation on alpha-crystallin structure and chaperone-like function. |
| Q42177527 | Effect of natural flavonoids, stilbenes and caffeic acid oligomers on protein glycation |
| Q91832080 | Effect of plant polyphenols on the formation of advanced glycation end products from β-lactoglobulin |
| Q32148865 | Effect of the degree of fatty acid unsaturation of rat heart mitochondria on their rates of H2O2 production and lipid and protein oxidative damage |
| Q36220872 | Elevated Serum Carboxymethyl-Lysine, an Advanced Glycation End Product, Predicts Severe Walking Disability in Older Women: The Women's Health and Aging Study I |
| Q37103996 | Elevated serum advanced glycation end products and poor grip strength in older community-dwelling women |
| Q37300130 | Elevated serum advanced glycation end products and their circulating receptors are associated with anaemia in older community-dwelling women |
| Q32163413 | Evaluation of protein modification during anti-viral heat bioprocessing by electrospray ionization mass spectrometry |
| Q36179583 | Genetic deficiency of neuronal RAGE protects against AGE-induced synaptic injury |
| Q82344767 | Genistein attenuates D-galactose-induced oxidative damage through decreased reactive oxygen species and NF-κB binding activity in neuronal PC12 cells |
| Q40673270 | Genotoxicity of advanced glycation end products in mammalian cells |
| Q90597460 | Glucoselysine is derived from fructose and accumulates in the eye lens of diabetic rats |
| Q46969687 | Glycated type 1 collagen induces endothelial dysfunction in culture |
| Q36724696 | Glycation does not modify bovine serum albumin (BSA)-induced reduction of rat aortic relaxation: the response to glycated and nonglycated BSA is lost in metabolic syndrome. |
| Q41342582 | Glycation of collagen: the basis of its central role in the late complications of ageing and diabetes |
| Q45231085 | Glycation of low-density lipoproteins by methylglyoxal and glycolaldehyde gives rise to the in vitro formation of lipid-laden cells |
| Q41687447 | Glycation, oxidation, and lipoxidation in the development of diabetic complications |
| Q36052417 | Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis |
| Q41134548 | Hepatic expression of galectin-3 and receptor for advanced glycation end products in patients with liver disease |
| Q28217486 | Histone H1 as a reporter protein to investigate glycation in bacteria |
| Q34216033 | How can thermal processing modify the antigenicity of proteins? |
| Q24795988 | How hyperglycemia promotes atherosclerosis: molecular mechanisms |
| Q34528130 | Identification in human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde-modified proteins |
| Q37692742 | Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis |
| Q73398876 | Imidazolone, a novel advanced glycation end product, is present at high levels in kidneys of rats with streptozotocin-induced diabetes |
| Q35766118 | Immunization of AGE-modified albumin inhibits diabetic nephropathy progression in diabetic mice |
| Q77323061 | Immunochemical approaches to AGE-structures: characterization of anti-AGE antibodies |
| Q77631578 | Immunochemical detection of N2-[1-(1-carboxy)ethyl]guanosine, an advanced glycation end product formed by the reaction of DNA and reducing sugars or L-ascorbic acid in vitro |
| Q37376119 | Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy |
| Q24561776 | Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients |
| Q43640428 | Immunohistochemical distribution and quantitative biochemical detection of advanced glycation end products in fetal to adult rats and in rats with streptozotocin-induced diabetes |
| Q48826779 | Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brain |
| Q33186938 | Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products |
| Q36851777 | Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure |
| Q53230702 | In situ methods for detection and localization of markers of oxidative stress: application in neurodegenerative disorders. |
| Q37363088 | Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. |
| Q44353029 | Increased level of glycoxidation product N(epsilon)-(carboxymethyl)lysine in rat serum and urine proteins with aging: link with glycoxidative damage accumulation in kidney |
| Q44182907 | Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study |
| Q54018838 | Inhibition of nitric oxide synthase activity by early and advanced glycation end products in cultured rabbit proximal tubular epithelial cells. |
| Q73025300 | Isolation, purification, and characterization of amadoriase isoenzymes (fructosyl amine-oxygen oxidoreductase EC 1.5.3) from Aspergillus sp |
| Q73593742 | Management of oxidative stress in the CNS: the many roles of glutathione |
| Q64097199 | Metabolic dysfunction in Emirati subjects in Abu Dhabi: Relationship to levels of soluble RAGEs |
| Q44326934 | Methylglyoxal metabolism and diabetic complications: roles of aldose reductase, glyoxalase-I, betaine aldehyde dehydrogenase and 2-oxoaldehyde dehydrogenase |
| Q60786650 | Methylglyoxal-modified arginine residues — a signal for receptor-mediated endocytosis and degradation of proteins by monocytic THP-1 cells |
| Q37036184 | N(epsilon)-(Carboxymethyl)lysine and Coronary Atherosclerosis-Associated Low Density Lipoprotein Abnormalities in Type 2 Diabetes: Current Status. |
| Q41616458 | Non-enzymatic modification of aminophospholipids by carbonyl-amine reactions. |
| Q73831601 | Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility |
| Q37261237 | Oat Protects against Diabetic Nephropathy in Rats via Attenuating Advanced Glycation End Products and Nuclear Factor Kappa B. |
| Q44640723 | Oleate, not ligands of the receptor for advanced glycation end-products, promotes proliferation of human arterial smooth muscle cells |
| Q36891939 | Oxidative stress, AGE, and atherosclerosis |
| Q73291326 | Oxygen is not required for the browning and crosslinking of protein by pentoses: relevance to Maillard reactions in vivo |
| Q36065338 | Pathophysiology and Medical Treatment of Carotid Artery Stenosis |
| Q37445850 | Plasma carboxymethyl-lysine, an advanced glycation end product, and all-cause and cardiovascular disease mortality in older community-dwelling adults |
| Q37294413 | Plasma protein pentosidine and carboxymethyllysine, biomarkers for age-related macular degeneration |
| Q42989378 | Presence of dopa and amino acid hydroperoxides in proteins modified with advanced glycation end products (AGEs): amino acid oxidation products as a possible source of oxidative stress induced by AGE proteins |
| Q35761110 | Prion Protein Protects against Renal Ischemia/Reperfusion Injury |
| Q47340371 | Probing Protein Glycation by Chromatography and Mass Spectrometry: Analysis of Glycation Adducts. |
| Q43824268 | Protein modification during anti-viral heat-treatment bioprocessing of factor VIII concentrates, factor IX concentrates, and model proteins in the presence of sucrose. |
| Q73258785 | Protein modification during antiviral heat bioprocessing |
| Q36969021 | RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases |
| Q42263637 | RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy |
| Q49413376 | RAGE-aptamer attenuates deoxycorticosterone acetate/salt-induced renal injury in mice |
| Q35739011 | Receptor for Advanced Glycation End-Products Signaling Interferes with the Vascular Smooth Muscle Cell Contractile Phenotype and Function |
| Q38182068 | Receptor for Advanced Glycation Endproducts (RAGE), Its Ligands, and Soluble RAGE: Potential Biomarkers for Diagnosis and Therapeutic Targets for Human Renal Diseases |
| Q35009768 | Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings |
| Q36212513 | Relationship of a dominant advanced glycation end product, serum carboxymethyl-lysine, and abnormal glucose metabolism in adults: The baltimore longitudinal study of aging |
| Q33603990 | Relationship of an advanced glycation end product, plasma carboxymethyl-lysine, with slow walking speed in older adults: the InCHIANTI study |
| Q36320068 | Role of N-(carboxymethyl)lysine in the development of ischemic heart disease in type 2 diabetes mellitus. |
| Q73705868 | Role of protein-bound carbonyl groups in the formation of advanced glycation endproducts |
| Q30425246 | Role of the Maillard reaction in diabetes mellitus and diseases of aging |
| Q33691339 | Serum carboxymethyl-lysine, a dominant advanced glycation end product, is associated with chronic kidney disease: the Baltimore longitudinal study of aging |
| Q34885399 | Serum carboxymethyl-lysine, an advanced glycation end product, is associated with increased aortic pulse wave velocity in adults |
| Q40395189 | Sleep-disordered breathing is associated with higher carboxymethyllysine level in elderly women but not elderly men in the cardiovascular health study |
| Q73783931 | Technical note. The serum concentration of the advanced glycation end-product N epsilon-(carboxymethyl)lysine is increased in uremia |
| Q34100112 | The biology of the receptor for advanced glycation end products and its ligands |
| Q51281402 | The effects of n-3 long-chain polyunsaturated fatty acid supplementation on AGEs and sRAGE in type 2 diabetes mellitus. |
| Q77530330 | The liver is the main site for metabolism of circulating advanced glycation end products |
| Q38778865 | The protective effects of pomelo extract (Citrus grandis L. Osbeck) against fructose-mediated protein oxidation and glycation |
| Q35896110 | The receptor for advanced glycation end products and risk of peripheral arterial disease, amputation or death in type 2 diabetes: a population-based cohort study |
| Q36199320 | The receptor for advanced glycation end products impairs collateral formation in both diabetic and non-diabetic mice |
| Q38241689 | The role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approach |
| Q89455914 | Trapa bispinosa Roxb. and lutein ameliorate cataract in type 1 diabetic rats |
| Q44590355 | Unusual susceptibility of heme proteins to damage by glucose during non-enzymatic glycation |
Search more.